Tissue Banking as a Part of the Transfusion Service

Question 1

1. Implant records must be kept for what duration?
   a. Ten years after the tissue has been harvested
   b. Indefinitely
   c. For a reasonable time to ensure that the recipient is not
   still alive when records are destroyed
   d. Ten years following the disposition or expiration of the
   tissue

Answer 1

d. Ten years following the disposition or expiration of the
tissue

Question 2

2. FDA CFR 1270 and 1271 include all of the following
   tissues except:
   a. Cancellous bone chips
   b. Blood vessels associated with vascular organs for
   transplant
   c. Cornea
   d. Heart valve

Answer 2

b. Blood vessels associated with vascular organs for
transplant

Question 3

3. Hospital tissue banks must register with the FDA if:
   a. Tissue for transplant is stored
   b. Autologous tissue is stored and issued
   c. Tissue is transferred to another facility
   d. The tissue bank is located outside the blood bank

Answer 3

c. Tissue is transferred to another facility

Question 4

4. The Joint Commission requires all of the following except:
   a. Hospital tissue banks must ensure that suppliers are
   complying with applicable state laws
   b. Tissue-manufacturing establishments must register
   with the FDA
   c. Hospitals must assign responsibility for overseeing the
   tissue program throughout the organization
   d. Hospital tissue banks must verify supplier’s registration
   with the FDA yearly

Answer 4

b. Tissue-manufacturing establishments must register
with the FDA

Question 5

5. The American Association of Tissue Banks (AATB) is:
   a. A mandatory accrediting agency for all tissue banks
   b. A voluntary accrediting agency for tissue-manufacturing
   establishments
   c. An historic name for the U.S. Navy Tissue Bank
   d. A subdivision within the AABB

Answer 5

b. A voluntary accrediting agency for tissue-manufacturing
establishments

Question 6

6. Transmission of malignancy in tissue:
   a. Is most likely to occur with the use of bone
   b. Is relatively common (1/10,000 cases)
   c. Is more likely to occur in whole organ transplant
   d. Has never been reported in cornea transplant

Answer 6

c. Is more likely to occur in whole organ transplant

Question 7

7. The medical director for the tissue bank can be:
   a. Any individual appointed by the hospital medical
   director
   b. The lead supervisor in the blood bank
   c. The head nurse/transplant coordinator from surgical
   nursing
   d. A qualified physician involved in tissue transplant or
   blood banking

Answer 7

d. A qualified physician involved in tissue transplant or
blood banking

Question 8

8. Notification of a recipient of tissue that has been recalled
   because of possible contamination:
   a. Should be conducted by the tissue bank director only
   b. Should be conducted by the patient’s transplanting
   surgeon
   c. The patient does not need to be told unless an infection develops
   d. The informed consent covers this contingency and no
   further notification is necessary

Answer 8

b. Should be conducted by the patient’s transplanting
surgeon

Question 9

9. Tissue receipt records must include all of the following
   except:
   a. Unique tissue identification number
   b. Name and address of tissue supplier
   c. Expiration date
   d. Tissue supplier’s FDA registration number

Answer 9

d. Tissue supplier’s FDA registration number

Question 10

10. Records that must be reviewed to determine donor
    eligibility by the tissue manufacturer include:
    a. Donor family history
    b. Records from any source pertaining to risk factors for
    communicable diseases
    c. Interview of next-of-kin
    d. Consent to harvest tissue

Answer 10

d. Consent to harvest tissue